Paradiem’s ResMed RMD Stock Holding History

Paradiem’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,501	Closed	-$3.02M	–	107
2021 Q3	$3.02M	Buy	11,501 +164	+1%	+$44.8K	0.9%	59
2021 Q2	$3.12M	Sell	11,337 -559	-5%	-$118K	0.97%	51
2021 Q1	$2.29M	Buy	11,896 +3,276	+38%	+$657K	0.75%	64
2020 Q4	$1.84M	Buy	+8,620	New	+$1.72M	0.78%	63

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Paradiem's RMD Position: Q4 2021 in Review

Paradiem sold out of ResMed (RMD) in Q4 2021, closing a stake of 11,501 shares — an estimated $3.02M sold.

Paradiem first reported a position in RMD in Q4 2020 and held it in 4 quarters. The position peaked at $3.12M in Q2 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

Paradiem reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
Paradiem sold 11,501 ResMed shares in Q4 2021, an estimated $3.02M.
Paradiem first reported a position in ResMed in Q4 2020 and held it in 4 quarters.
Paradiem's ResMed position peaked at $3.12M in Q2 2021.
723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Paradiem's 13F filing for Q4 2021, filed 3 Feb 2022.